Introduction
============

Methicillin-resistant *Staphylococcus aureus* (MRSA) is a leading cause of nosocomial infection.[@b1-idr-11-113] Vancomycin is usually used to treat MRSA infections, but high-level vancomycin-resistant *S. aureus* (VRSA) has emerged mainly due to the acquisition of the *vanA* operon from Enterococci.[@b2-idr-11-113] There are also VRSA isolates with lower levels of vancomycin resistance, including vancomycin-intermediate *S. aureus* (VISA) and heterogeneous VISA (hVISA).[@b3-idr-11-113] The causes for the different levels of vancomycin resistance in MRSA are not completely clear.[@b4-idr-11-113],[@b5-idr-11-113]

Identification of VISA and hVISA is conventionally done by determination of population analysis profile and area under the curve ratio (PAP/AUC). However, PAP/AUC is very labor-intensive and not practical for clinical diagnosis. Transcriptome and proteome analyses of MRSA isolates have revealed a link between nucleotide sequence variations of several genes and vancomycin resistance.[@b6-idr-11-113],[@b7-idr-11-113] These genes include those of the two-component systems, such as *vraRS*, *graRS* or *walRK*,[@b6-idr-11-113],[@b8-idr-11-113],[@b9-idr-11-113] and those involved in cell wall synthesis, such as *upps*, *fmtC* and *srtA*.[@b9-idr-11-113]--[@b11-idr-11-113] Single-nucleotide variations (SNVs) of genes related to antibiotic resistance have also been described.[@b8-idr-11-113],[@b9-idr-11-113],[@b12-idr-11-113],[@b13-idr-11-113] These SNVs may allow differentiation between vancomycin-sensitive *S. aureus* (VSSA) and VISA.

Previous studies on hVISA and VISA strains have revealed 60 genes that may be associated with vancomycin resistance.[@b4-idr-11-113],[@b9-idr-11-113],[@b10-idr-11-113],[@b14-idr-11-113]--[@b23-idr-11-113] We hypothesized that some nucleotide sequence variations in these genes correlate with the difference in vancomycin susceptibility of VSSA and VISA isolates. To test this hypothesis, we investigated the prevalence of SNVs of these 60 genes and found 29 SNVs (in 12 genes) that were more common in hVISA and VISA than in VSSA isolates. Among them, three novel amino acid sequence variations including Q692E in FmtC, T287I in HtrA and K101E in Upps proteins were found to be significantly associated with vancomycin resistance.

Materials and methods
=====================

Bacteria strains and growth conditions
--------------------------------------

In total, 87 MRSA isolates were used in this study, including 72 from Chang Gung Memorial Hospital, 3 from National Tai-wan University Hospital, 8 from Tri-Service General hospital (TSGH) and 2 each from Chi Mei Medical Center and China Medical University Hospital. These isolates were collected from 2009 to 2014. Detailed information of these isolates is presented in [Table 1](#t1-idr-11-113){ref-type="table"}. All isolates were stored at −80°C and grown on tryptic soy agar plates at 37°C for 16 hours for the studies.

Whole-genome sequencing and polymerase chain reaction (PCR)
-----------------------------------------------------------

The whole genome of two VISA isolates (TSGH205 and TSGH243) was sequenced. Genomic DNA of each isolate was isolated and sonicated to generate fragments of 300--500 bp for construction of a DNA library, which was then subjected to Illumina next-generation sequencing. Raw sequence data generated were filtered and assembled for analysis using the CLC Genomics Workbench (QIAGEN, Venlo, the Netherlands). Genes selected for investigation of vancomycin resistance and PCR primers used to amplify these genes are shown in [Table 2](#t2-idr-11-113){ref-type="table"}. PCRs were performed in a buffer containing 10 mM Tris-HCl (pH 8.0), 1.5 mM MgCl~2~ and 50 mM KCl under the following conditions: 5 minutes at 95°C, followed by 35 cycles of 30 seconds at 95°C for denaturation, 30 seconds at 55°C for primer annealing and 1 minute at 72°C for extension, and 5 minutes at 72°C for final extension. PCR products were verified by sequencing.

Minimum inhibition concentration (MIC) E-tests
----------------------------------------------

E-test was performed to determine the vancomycin MIC of VSSA, hVISA and VISA isolates. Cells of an overnight culture of each isolate were suspended in 0.9% NaCl solution, adjusted to 0.5 McFarland unit and spread evenly on a Mueller--Hinton agar plate. An E-test strip (bioMérieux, Durham, NC, USA) was placed on the agar plate, which was then incubated at 35°C overnight to determine MIC values.

Population analysis profile/area under the curve
------------------------------------------------

PAP/AUC was performed to identify hVISA and VISA isolates as previously described.[@b24-idr-11-113],[@b25-idr-11-113] Briefly, serial dilutions of the overnight culture of an isolate were plated on brain heart infusion agar plates containing different concentrations of vancomycin (0, 0.5, 1, 1.5, 2, 3, 4, 6 and 8 μg/mL). After incubation at 35°C for 48 hours, colony-forming units (CFUs) of the isolate were determined and graphed as log~10~CFU/mL value versus vancomycin concentration to calculate the AUC. Reference strains Mu3 and Mu50 were analyzed in an identical manner to serve as hVISA and VISA controls, respectively. To distinguish VSSA, hVISA and VISA, the ratio (PAP/AUC value) of the AUC of an isolate to the AUC of Mu3 was calculated. The following ratios were used for identification of VSSA, hVISA and VISA populations: VSSA, \<0.9; hVISA, 0.9--1.3; VISA, \>1.3.

Results
=======

Nucleotide sequence variations in genes related to vancomycin resistance
------------------------------------------------------------------------

The 87 MRSA isolates used in this study included 30 VSSA, 41 hVISA and 16 VISA isolates ([Table 1](#t1-idr-11-113){ref-type="table"}). To test the hypothesis that some SNVs in the previously identified 60 genes ([Table S1](#SD1-idr-11-113){ref-type="supplementary-material"}) correlate with the difference in vancomycin susceptibility of VSSA and VISA isolates, the nucleotide sequences of these 60 genes in these MRSA isolates were examined. To simplify the bioinformatics work, this examination was performed in a stepwise manner to gradually narrow down the scope of analysis. Genes with SNVs were first identified, followed by determination of the prevalence of the SNVs in the MRSA isolates, identification of novel SNVs and then correlation of these novel SNVs with vancomycin resistance.

For the first step of analysis, the sequences of the 60 genes in two each of VSSA (N315 and JH1) and VISA (TSGH205 and TSGH243) isolates were aligned and compared. These four strains were selected because their entire genome had been sequenced. The two VSSA strains (N315 and JH1) were found to differ in nucleotide sequences in 13 genes, whereas the two VISA strains (TSGH205 and TSGH243) differed in nucleotide sequences in 25 genes, indicating that genes in the VISA isolates are more variable. Most of these sequence variations are SNVs. After excluding SNVs that were common in the two VSSA and two VISA strains, 29 SNVs in the following 12 genes were found in both VISA strains (TSGH205 and TSGH243): *fmtC, graR, graS, htrA, mecA, pbp2, pbp4, srtA, tcaA, upps, vraR* and *vicK* ([Table 3](#t3-idr-11-113){ref-type="table"}). These genes have been shown to be related to the two-component system (*graR, graS, vicK* and *vraR*), cell membrane synthesis (*tcaA*), cell wall synthesis (*mecA, pbp2, pbp4* and *srtA*) or vancomycin resistance (*htrA, fmtC* and *upps*).[@b10-idr-11-113],[@b11-idr-11-113]

Prevalence of the 29 SNVs in VSSA, hVISA and VISA isolates
----------------------------------------------------------

In the second step of analysis, the association of these 29 SNVs with vancomycin resistance was determined. To achieve the goal, the nucleotide sequences of the aforementioned 12 genes of 16 additional clinical isolates were compared, including five VSSA, nine hVIS and two VISA strains. Results showed that two VSSA, five hVISA and all VISA isolates had the same 29 SNVs. Six of these SNVs were novel and resulted in the following amino acid changes: Q692E in FmtC; T278I, P306L and I311T in HtrA; and I63V and K101E in Upps ([Table 4](#t4-idr-11-113){ref-type="table"}).

Amino acid sequence variations in HtrA, FmtC and Upps associated with vancomycin resistance
-------------------------------------------------------------------------------------------

In the third step of analysis, the role of these six novel SNVs in vancomycin resistance was then investigated by detecting their presence in 69 additional MRSA isolates. These isolates included 25 VSSA, 32 hVISA and 12 VISA isolates. Among the six amino acid variations, P306L and I311T in HtrA and I63V in Upps were present in the majority of VSSA isolates (P306L, 86.7%; I311T, 86.7%; I63V, 76.7%), as shown in [Table 5](#t5-idr-11-113){ref-type="table"}, suggesting that these three amino acid variations are not associated with vancomycin resistance. The other three amino acid variations (T278I in HtrA, K101E in Upps and Q692E in FmtC) were found to be present in the majority of hVISA and VISA isolates, but only in a small number of VSSA isolates. The percentages of isolates with these sequence variations were the following: HtrA T278I: 87.8% hVISA, 93.8% VISA and 25.7% VSSA isolates; Upps K101E: 87.8% hVISA, 87.5% VISA and 22.9% VSSA isolates; and FmtC Q692E: 87.8% hVISA, 87.5% VISA and 25.7% VSSA isolates ([Tables 5](#t5-idr-11-113){ref-type="table"}[](#t6-idr-11-113){ref-type="table"}--[7](#t7-idr-11-113){ref-type="table"}).

Discussion
==========

Previous studies have revealed 60 genes that may be related to vancomycin resistance,[@b6-idr-11-113],[@b9-idr-11-113] suggesting that vancomycin resistance is a complex phenomenon and is mediated not by a single gene but by a group of genes. Among these 60 genes, 41 were found to be associated with vancomycin resistance by expression analysis;[@b10-idr-11-113],[@b14-idr-11-113],[@b16-idr-11-113],[@b20-idr-11-113]--[@b23-idr-11-113] 8 were found by overexpression, deletion or insertion mutations;[@b10-idr-11-113],[@b15-idr-11-113],[@b18-idr-11-113],[@b19-idr-11-113] 11 were found by analysis of SNVs.[@b4-idr-11-113],[@b9-idr-11-113],[@b11-idr-11-113],[@b17-idr-11-113],[@b20-idr-11-113] In this study, we found 29 SNVs in the following 12 genes: *fmtC*, *graR*, *graS*, *htrA*, *mecA*, *pbp2*, *pbp4*, *srtA*, *tcaA*, *upps*, *vraR* and *vicK* ([Table 3](#t3-idr-11-113){ref-type="table"}). Six of these 29 SNVs in *fmtC*, *htrA* and *upps* are novel. Since we only examined the sequences of these 12 genes in a limited number (87) of MRSA isolates, it is conceivable that other isolates may have other important sequence variations that were not detected in this study.

Of the 12 genes with SNVs, *graR, graS, vicK* and *vraR* are related to the two-component system.[@b9-idr-11-113] The others (*mecA*, *pbp2*, *pbp4*, *srtA*, *tcaA*, *fmtC*, *htrA* and *upps*) are more closely associated with vancomycin resistance. The *mecA* gene encodes the penicillin-binding protein 2a (PBP2a), which plays a role in resistance to beta-lactam antibiotics. Previous studies have shown that vancomycin treatment triggers deletions in the *mecA* gene.[@b26-idr-11-113],[@b27-idr-11-113] The N146K, N204K and G246E mutations in the MecA protein that we found in this study are located near or in the dimerization domain of PBP2a (KEGG database; <http://www.kegg.jp/ssdb-bin/ssdb_motif?kid=sav:SAV0041>) and would cause conformational changes of PBP2a. A recent study showed that these mutations (N146K, N204K and G246E) are highly associated with ceftaroline resistance,[@b28-idr-11-113] suggesting that they are also related to vancomycin susceptibility.

The *pbp2* and *pbp4* genes encode other penicillin-binding proteins (PBPs), which are also major components of the cell wall. The N-terminal domain of these PBPs encodes a glycosyltransferase, which catalyzes glycan chain polymerization from lipid II. Their C-terminal domain encodes a transpeptidase, which cross-links glycan chains.[@b29-idr-11-113] In addition to the glycosyltransferase and transpeptidase domains, *PBP4* also has a domain encoding a carboxypeptidase, which hydrolyzes the C-terminal D-Ala-D-Ala peptide bond of the precursor of peptidoglycan.[@b30-idr-11-113] Previous studies have shown that vancomycin treatment increases the expression of *pbp2*, but decreases the expression of *pbp4* in *S. aureus*.[@b31-idr-11-113] It has been shown that *pbp4* mutations result in a decrease in its carboxypeptidase activity, leading to increased production of D-Ala-D-Ala termini in peptidoglycan and decreased vancomycin-binding affinity.[@b31-idr-11-113] The sequence variation S189T in PBP4, we found in this study, is located in its carboxypeptidase domain (KEGG database; <http://www.kegg.jp/ssdb-bin/ssdb_motif?kid=sav:SAV0642>) and conceivably would reduce its activity.

Previous studies on PBP2 have found that mutations in the transpeptidase domain of PBP2 increase the susceptibility of *S. aureus* to ceftizoxime.[@b32-idr-11-113] The C197Y, A420V and A557T mutations in PBP2 found in this study are located in its trans-peptidase and transglycosylase domains (KEGG database; <http://www.kegg.jp/ssdb-bin/ssdb_motif?kid=sav:SAV1450>). The C197Y mutation has been shown to be associated with the susceptibility of *S. aureus* to ceftaroline,[@b33-idr-11-113] which is effective for treatment of hVISA or VISA infections.[@b34-idr-11-113] Although the other two mutations have not been investigated, it is conceivable that they will alter the activity of PBP2.

The *srtA* gene encodes sortase A, which is involved in the modification of cell surface proteins.[@b35-idr-11-113] Transcriptome analysis revealed a decreased expression of *srtA* by vancomycin treatment.[@b10-idr-11-113] The N167K mutation identified in this study is located in the sortase domain (KEGG database; <http://www.kegg.jp/ssdb-bin/ssdb_motif?kid=sav:SAV2528>) and, thus, would decrease its activity.

The *tcaA* gene encodes a membrane protein that has been shown to be associated with glycopeptide resistance.[@b36-idr-11-113] Structural analysis showed that amino acid residues 195--322 of the TcaA protein contain an OprB porin domain (<http://www.kegg.jp/ssdb-bin/ssdb_motif?kid=sauf:X998_2340>) of the ABC transporter, which plays a major role in carbohydrate uptake. Previous studies have shown that the ABC transporter is also involved in bacterial multidrug resistance.[@b37-idr-11-113] Since the five amino acid variations (L218P, Y237H, T262S, R283H and G312D) in the TcaA protein we found are all located in its OprB porin domain, it is conceivable that these mutations will affect vancomycin resistance.

In this study, six novel SNVs were found in *fmtC*, *htrA* and *upps* genes that have not been shown to be associated with vancomycin resistance. Three of them (Q692E in FmtC, T287I in HtrA and K101E in Upps) were correlated with vancomycin resistance ([Tables 5](#t5-idr-11-113){ref-type="table"}[](#t6-idr-11-113){ref-type="table"}--[7](#t7-idr-11-113){ref-type="table"}). The *htrA* gene encodes a serine protease of the DegP family.[@b38-idr-11-113] Previous studies have shown that HtrA can suppress the production and secretion of bacteriocin by *Streptococcus pneumonia*.[@b39-idr-11-113] Bacteriocin-producing enterococci and staphylococci also have been described.[@b40-idr-11-113]--[@b42-idr-11-113] There have been no reports on the relationship between bacteriocin production and vancomycin resistance. Bacteriocin production has been shown to augment niche competition by enterococci in the gastrointestinal tract.[@b43-idr-11-113] It is unknown whether any of the MRSA isolates examined in this study produces bacteriocin. Therefore, the mechanisms by which HtrA mediates vancomycin resistance remain to be investigated. The T278I mutation is predicted to be located in the coil structure of HtrA (<http://www.ebi.ac.uk/interpro/protein/Q5HH63>). It is possible that this mutation alters the secondary structure and thus the enzymatic activity of HtrA, leading to vancomycin resistance.

The *upps* gene encodes undecaprenyl pyrophosphate synthase, which catalyzes the formation of undecaprenyl pyrophosphate (UPP) by condensing farnesyl pyrophosphate with eight molecules of isopentenyl pyrophosphate.[@b44-idr-11-113] UPP is a lipid carrier during peptidoglycan synthesis. Inhibition of Upps has been shown to suppress cell wall synthesis and decrease the susceptibility of bacteria to vancomycin.[@b11-idr-11-113] Structural prediction (EMBL-EBL; <http://www.ebi.ac.uk/interpro/protein/A0A1D4QTF1>) revealed that Upps has a dimer interface residue at amino acid position 101. Thus, the K101E variation discovered in this study very likely would destabilize Upps, leading to vancomycin resistance.

The *fmtC* (also called *mprF*) gene encodes phosphatidylglycerol lysyltransferase that mediates lysinylation of phosphatidylglycerol.[@b45-idr-11-113] Mutations in *fmtC* in *S. aureus* and *Bacillus subtilis* have been shown to cause a decrease in the production of lysyl-peptidoglycan, thus increasing negative charges of the cell membrane and reducing the susceptibility of bacteria to vancomycin and daptomycin.[@b46-idr-11-113],[@b47-idr-11-113] The Q692E mutation, that we found in this study, is located in the IPR02430 domain (EMBL-EBL; <http://www.ebi.ac.uk/interpro/entry/IPR024320>), which is involved in the transfer of the lysyl group from l-lysyl-tRNA to membrane-bound peptidoglycan. This mutation very likely will disrupt this process, resulting in vancomycin resistance.

Limitations of this study include limited number of MRSA isolates examined and lack of detailed information of infections caused by the isolates, correlation between gene expression levels and vancomycin resistance, and functional studies of the SNVs. Therefore, the possibility that the SNVs discovered in this study may not completely correlate with vancomycin resistance of MRSA isolates still exists.

Conclusion
==========

We have identified 29 SNVs that are more prevalent in hVISA and VISA than in VSSA isolates. Through sequence comparison of 87 isolates, we demonstrated that three novel SNVs in *htrA*, *upps* and *fmtC* genes are associated with vancomycin resistance. Since other environmental factors such as coinfections and patient's conditions may also affect vancomycin resistance, allelic replacement or complementation of these SNVs needs to be performed to confirm the roles of these mutations in vancomycin resistance.

Supplementary material
======================

###### 

Comparative analysis gene list

  Accession number   Gene name   Location                        Gene function                                                                               Gene mutation type                                                                                  Reference
  ------------------ ----------- ------------------------------- ------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- --------------------------------------
  SA1843             *agrC*      2080353--2081468                Accessory gene regulator C                                                                  SNP (L193stop)                                                                                      [@b4-idr-11-113]
  SA0366             *ahpC*      422549--423118                  Alkyl hydroperoxide reductase subunit C                                                     Transcriptome analysis data                                                                         [@b22-idr-11-113]
  SA1226             *asd*       1401012--1402001                Aspartate semialdehyde dehydrogenase                                                        Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA1557             *ccpA*      1784194--1785138                Catabolite control protein A                                                                Knock out deletion                                                                                  [@b15-idr-11-113]
  SA0723             *clpP*      827630--828217                  ATP-dependent Clp protease proteolytic subunit                                              Truncating deletion, SNP (M1V, H83R, R152H)                                                         [@b20-idr-11-113]
  SA1096             *clpQ*      1242040--1242585                Heat shock protein HslV                                                                     Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA0480             *ctsR*      560629--561090                  Transcription repressor of class III stress genes homologue                                 Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA0639             *cydC*      731989--733620                  Hypothetical protein, similar to ABC transporter required for expression of cytochrome bd   Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA0640             *cydD*      733617--735290                  Hypothetical protein, similar to ABC transporter required for expression of cytochrome bd   Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA1228             *dapB*      1402887--1403609                Dihydrodipicolinate reductase                                                               Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA1206             *fmtA*      1379204--1380466                Factor essential for expression of methicillin                                              Transcriptome analysis data                                                                         [@b21-idr-11-113]
  SA1193             *fmtC*      1363612--1366134                Oxacillin resistance-related FmtC protein                                                   Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0309             *geh*       365458--367533                  Glycerol ester hydrolase                                                                    Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA0430             *gltB*      490664--495163                  Glutamate synthase large subunit                                                            Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA0614             *graR*      708245--708919                  Hypothetical protein, similar to two-component response regulator                           SNP (T11A, E15K, S79F, D148Q, F151L, N197S)                                                         [@b9-idr-11-113]
  SA0615             *graS*      708912--709952                  Hypothetical protein, similar to two-component sensor histidine kinase                      SNP (L26F, I59L, T224I)                                                                             [@b9-idr-11-113]
  SA0879             *htrA*      997117--999426                  Serine protease HtrA                                                                        Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA1859             *ilvB*      2099308--2101077                Acetolactate synthase large subunit                                                         Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA0980             *isdE*      1109815--1110693                Hypothetical protein, similar to ferrichrome ABC transporter                                SNP (A48V)                                                                                          [@b17-idr-11-113]
  SA1997             *lacA*      complement (2268598--2269026)   Galactose-6-phosphate isomerase LacA subunit                                                Transcriptome analysis data                                                                         [@b16-idr-11-113], [@b20-idr-11-113]
  SA1996             *lacB*      complement (2268067--2268582)   Galactose-6-phosphate isomerase LacB subunit                                                Transcriptome analysis data                                                                         [@b16-idr-11-113], [@b20-idr-11-113]
  SA1995             *lacC*      complement (2267122--2268054)   Tagatose-6-phosphate kinase                                                                 Transcriptome analysis data                                                                         [@b16-idr-11-113], [@b20-idr-11-113]
  SA1994             *lacD*      complement (2266138--2267118)   Tagatose-1,6-diphosphate aldolase                                                           Transcriptome analysis data                                                                         [@b16-idr-11-113], [@b20-idr-11-113]
  SA2103             *lytR*      2365947--2366894                Hypothetical protein, similar to lyt divergon expression                                    Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0038             *mecA*      complement (45031--47037)       Penicillin-binding protein 2 prime                                                          Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0344             *metE*      complement (401175--403403)     5-Methyltetrahydropteroyltriglutamate-homocysteine methyltransferase                        Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0641             *MgrA*      complement (735417--735860)     Hypothetical protein; regulatory protein involved in autolytic activity                     Deletion                                                                                            [@b10-idr-11-113]
  SA0997             *murI*      1130843--1131643                Glutamate racemase                                                                          Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA1926             *murZ*      complement (2174362--2175621)   UDP-*N*-acetylglucosamine 1-carboxylvinyl transferase 2                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0847             *oppD*      960028--961110                  Oligopeptide transport system ATP-binding protein OppD homolog                              Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA2237             *opuCA*     complement (2511766--2512998)   Glycine betaine/carnitine/choline ABC transporter opuCA                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA2236             *opuCB*     complement (2511134--2511769)   Glycine betaine/carnitine/choline ABC transporter opuCB                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA2235             *opuCC*     complement (2510176--2511117)   Glycine betaine/carnitine/choline ABC transporter opuCC                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA2234             *opuCD*     complement (2509481--2510176)   Glycine betaine/carnitine/choline ABC transporter opuCD                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA1283             *pbp2*      1486656--1488839                Penicillin-binding protein 2                                                                Overexpression                                                                                      [@b10-idr-11-113]
  SA0598             *pbp4*      complement (690688--691983)     Penicillin binding protein 4                                                                Overexpression/allelic replacement inactivation                                                     [@b10-idr-11-113]
  SA1024             *pbpA*      1158054--1160288                Penicillin-binding protein 1                                                                Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA1659             *prsA*      1892718--1893680                Peptidyl-prolyl *cis/trans* isomerase homolog                                               Deletion frameshift mutation                                                                        [@b10-idr-11-113]
  SA0963             *pycA*      1091242--1094694                Pyruvate carboxylase                                                                        Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0500             *rpoB*      579620--583171                  RNA polymerase beta chain                                                                   SNP (G171D, A447V, D471Y, H481Y)                                                                    [@b4-idr-11-113]
  SA1872             *rsbU*      complement (2119821--2120822)   SigmaB regulation protein RsbU                                                              Transcriptome analysis data                                                                         [@b14-idr-11-113]
  SA2094             *SA2094*    complement (2353833--2355233)   Hypothetical protein, similar to Na^+^/H^+^ antiporter                                      SNP (A94T)                                                                                          [@b17-idr-11-113]
  SA0573             *SarA*      666347--666721                  Staphylococcal accessory regulator A                                                        Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA1691             *sgtB*      complement (1938571--1939380)   Hypothetical protein, similar to penicillin-binding protein 1A/1B                           Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0111             *sirA*      complement (127549--128541)     Iron-regulated ABC transporter                                                              Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA0110             *sirB*      complement (126538--127533)     Iron-regulated ABC transporter siderophore permease protein SirB                            Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA0109             *sirC*      complement (125543--126460)     Iron-regulated ABC transporter siderophore permease protein SirC                            Transcriptome analysis data                                                                         [@b20-idr-11-113]
  SA0456             *SpoVG*     526376--526702                  Stage V sporulation protein G homolog                                                       Deletion                                                                                            [@b19-idr-11-113]
  SA2316             *srtA*      complement (2600886--2601506)   Sortase                                                                                     Transcriptome analysis data                                                                         [@b10-idr-11-113]
  SA0592             *tagA*      685072--685836                  Teichoic acid biosynthesis protein                                                          Transcriptome analysis data                                                                         [@b23-idr-11-113]
  SA2146             *tcaA*      complement (2411587--2412969)   TcaA protein                                                                                SNP (M202T, L218P, T279I, R283H, G312D)                                                             [@b9-idr-11-113]
  SA0857             *trfA*      971601--972320                  Hypothetical protein, similar to negative regulator of genetic competence MecA              Insertion inactivation                                                                              [@b18-idr-11-113]
  SA0858             *trfB*      972441--973427                  Hypothetical protein, similar to transcription factor                                       Insertion inactivation                                                                              [@b18-idr-11-113]
  SA1103             *upps*      1248834--1249604                Undecaprenyl pyrophosphate synthetase                                                       Point mutation on ribosome binding site                                                             [@b11-idr-11-113]
  SA0018             *vicK*      25648--27474                    Two-component response regulator                                                            SNP (L10F, N48K, R222K/I, G275V, R282C, F330S, V380I, S437F, A468T, T492K, D496N, V494L, A567D)     [@b20-idr-11-113]
  SA0017             *vicR*      24928--25635                    Two-component response regulator                                                            Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA1700             *vraR*      complement (1946742--1947371)   Two-component response regulator                                                            SNP (E59D, A113V, S164P, S329L)                                                                     [@b9-idr-11-113], [@b20-idr-11-113]
  SA1701             *vraS*      complement (1947361--1948404)   Two-component response regulator                                                            SNP (I5N, G9V, G88D, T104A, L123H, S167N, F243S, A260V, K272I, A314V, L315M, I317T, F321L, P327S)   [@b9-idr-11-113], [@b20-idr-11-113]
  SA1095             *xerC*      1241147--1242043                Site-specific recombinase XerC homolog                                                      Transcriptome analysis data                                                                         [@b16-idr-11-113]
  SA1702             SA1702      1948401--1949102                Conserved hypothetical protein                                                              SNP (E56G, L86I, Q136H)                                                                             [@b9-idr-11-113]
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###### 

MRSA strains used in this study

  Vancomycin phenotype (number)   Source[a](#tfn1-idr-11-113){ref-type="table-fn"} (number)                                                          Strain IDs                                                                                                                                            Reference
  ------------------------------- ------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  VSSA (30)                       CGMH (30)                                                                                                          43, 46, 49, 64, 827--851                                                                                                                              This study
  hVISA (41)                      CGMH (34)                                                                                                          2, 6, 9, 10, 22, 23, 33, 37, 42, 50, 55, 57, 60, 62, 72, 75, 82, 85, 103, 104, 108, 199, 208, 215, 216, 222, 224, 232, 236, 238, 241, 246, 247, 250   This study
  TSGH (2)                        5046, 5047                                                                                                         [@b1-idr-11-113], [@b2-idr-11-113]                                                                                                                    
  NTUH (3)                        9140, 9148, 9095                                                                                                                                                                                                                                                         
  CMMC (2)                        2012, 2086                                                                                                                                                                                                                                                               
  VISA (16)                       CGMH (8)                                                                                                           36, 80, 852--857                                                                                                                                      This study
  TSGH (6)                        188, 204, 205[b](#tfn2-idr-11-113){ref-type="table-fn"}, 218, 243[b](#tfn2-idr-11-113){ref-type="table-fn"}, 257   [@b1-idr-11-113], [@b3-idr-11-113], [@b4-idr-11-113]                                                                                                  
  CMUH (2)                        2021, 4022                                                                                                         [@b2-idr-11-113]                                                                                                                                      

**Notes:**

All strains were collected from blood cultures at different times.

Whole-genome sequenced strains.

**Abbreviations:** CGMH, Chang Gung Memorial Hospital; CMMC, Chi Mei Medical Center; CMUH, China Medical University Hospital; hVISA, heterogeneous vancomycin-intermediate *Staphylococcus aureus*; MRSA, methicillin-resistant *Staphylococcus aureus*; NTUH, National Taiwan University Hospital; TSGH, Tri-Service General hospital; VISA, vancomycin-intermediate *Staphylococcus aureus*; VSSA, vancomycin-sensitive *Staphylococcus aureus*.

###### 

Primers used in this study

  Primer       Sequence (5′→3′)
  ------------ --------------------------
  fmtC-F1      GGAGATCCGTTAGGTGATGAAA
  fmtC-R1      TGGTAAATCTAACTCTGGCAACC
  graRS-F      TATTTTGGCCGATTTATTACTTTA
  graSR-R      CCTTTAGGCTTTGGCACTTGT
  htrA-F       GATTCAGACAGCTCGATGCAG
  htrA-R       GGCCAATACATCATCCAAAAC
  mecA-F       GTGGAGACGAGCACTAATAACC
  mecA-R       GAAGTTGTAGCAGGAACACAAATG
  pbp2-F       GAACTTGACTGGTGGATTTGG
  pbp2-R       GCCCATCCACACTGACATAG
  pbp4-40R     TACAGAAGGCATTTCGACG
  pbp4-F1      AGTATGGACAATCGCAGACC
  srtA-F       GCAGCATATTTGTTTGCTAAACC
  srtA-R       CAATGACACGTCGTCATTGG
  tcaA-R1      TCTTGCGAGCCTTGTTCAAG
  tcaA-R-new   GCACCTACCAAGCAACCAAT
  upps-F       TTATGGATGGTAATGGGCGA
  upps-R       GCGTCTTTGACGTGACTGAT
  vicK-F       GAGTATGCCAACCGTCAAGA
  vicK-R       ACGATACGAATACGTCCACG
  vraSR-F1     TCAGGTACACGTATCGAGGT
  vraR-R1      TTGTCGGTGCTGAAATCAAT

###### 

Sequence variations in VSSA and VISA strains

  Gene ID             Gene name   Amino acid variation (nucleotide variation)   VSSA   VSSA   VISA   VISA
  ------------------- ----------- --------------------------------------------- ------ ------ ------ ------
  SA1193              *fmtC*      Q692E (C2074G)                                Q      Q      E      E
  SA0614              *graR*      **D148Q** (G442C, T444G)                      D      D      Q      Q
  SA0615              *graS*      **L26F** (G78C)                               L      L      F      F
  I59L (A175T)        I           I                                             L      L             
  **T224I** (C671T)   T           T                                             I      I             
  SA0879              *htrA*      T278I (C833T)                                 T      T      I      I
  P306L (T917C)       L           L                                             P      P             
  I311T (T932C)       I           I                                             T      T             
  SA0038              *mecA*      N146K (T438A)                                 N      N      K      K
  N204K (T612G)       N           N                                             K      K             
  G246E (G738A)       G           G                                             E      E             
  SA1283              *pbp2*      C197Y (G591A)                                 C      Y      Y      Y
  A420V (C1259T)      A           A                                             V      V             
  A557T (G1669A)      A           A                                             T      T             
  SA0598              *pbp4*      S189T (T565A)                                 S      S      T      T
  S395C (A1183T)      S           S                                             C      C             
  A409T (G1225A)      A           A                                             T      T             
  SA2316              *srtA*      N57K (T171A)                                  N      N      K      K
  E167G (A500G)       E           E                                             G      G             
  SA246               *tcaA*      **L218P** (T653C)                             L      P      P      P
  Y237H (T709C)       Y           Y                                             H      H             
  T262S (A784T)       T           T                                             S      S             
  **R283H** (A848G)   R           R                                             R      H             
  **G312D** (G935A)   G           G                                             G      D             
  SA1103              *upps*      I63V (A187G)                                  I      I      V      V
  K101E (A301G)       K           K                                             E      E             
  SA1700              *vraR*      E59D (A177T)                                  E      E      E      D
  SA0018              *vicK*      R222K (G665A)                                 R      R      K      K

**Note:** Sequences in bold typeface have been reported in previous studies.

**Abbreviations:** TSGH, Tri-Service General hospital; VISA, vancomycin-intermediate *Staphylococcus aureus*; VSSA, vancomycin-sensitive *S. aureus*.

###### 

Amino acid sequence variations in 16 MRSA isolates

  Types         Amino acid   VSSA (5)   hVISA (9)   VISA (2)                                                                                     
  ------------- ------------ ---------- ----------- ---------- ------ ------ ------ ------ ------ ------ ----- ------ ------ ----- ------ ------ ------
  CGMH strain                43         46          234        49     64     33     250    236    241    10    50     60     215   246    36     80
  VAN MIC                    1          1           2          1.5    1      2      2      2      2      2     2      2      2     2      2      2
  PAP/AUC                    0.82       0.65        0.73       0.83   0.69   0.94   0.91   1.14   0.93   1.2   0.91   0.98   1     0.95   1.47   1.37
  *fmtC*        Q692E        −          −           −          \+     \+     −      −      −      −      \+    \+     \+     \+    \+     \+     \+
  *graR*        **D148Q**    −          −           −          \+     \+     −      −      −      \+     \+    \+     \+     \+    \+     \+     \+
  *graS*        **L26F**     −          −           −          \+     \+     −      −      \+     −      \+    \+     \+     \+    \+     \+     \+
  **I59L**      −            −          −           \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  **T224I**     −            −          −           \+         \+     −      −      \+     \+     \+     \+    \+     \+     \+    \+     \+     
  *htrA*        T278I        −          −           −          \+     \+     −      −      −      −      \+    \+     \+     \+    \+     \+     \+
  P306L         −            −          \+          \+         \+     −      −      −      \+     \+     \+    \+     \+     \+    \+     \+     
  I311T         −            −          \+          \+         \+     −      −      −      \+     \+     \+    \+     \+     \+    \+     \+     
  *mecA*        N146K        −          −           \+         \+     \+     −      −      −      −      \+    \+     \+     \+    \+     \+     \+
  N204K         −            −          \+          \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  G246E         −            −          \+          \+         \+     −      −      −      \+     \+     \+    \+     \+     \+    \+     \+     
  *pbp2*        C197Y        \+         \+          \+         \+     \+     \+     \+     \+     \+     \+    \+     \+     \+    \+     \+     \+
  A420V         −            −          −           \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  A557T         −            −          −           \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  *pbp4*        S189T        −          −           −          \+     \+     −      \+     −      −      \+    \+     \+     \+    \+     \+     \+
  S395C         −            −          −           \+         \+     −      \+     −      −      \+     \+    \+     \+     \+    \+     \+     
  A409T         −            −          −           \+         \+     −      \+     −      −      \+     \+    \+     \+     \+    \+     \+     
  *srtA*        N57K         −          −           \+         \+     \+     −      −      \+     \+     \+    \+     \+     \+    \+     \+     \+
  E167G         −            −          −           \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  *tcaA*        **L218P**    −          −           \+         \+     \+     −      \+     −      \+     \+    \+     \+     \+    \+     \+     \+
  Y237H         −            −          −           \+         \+     −      \+     −      \+     \+     \+    \+     \+     \+    \+     \+     
  T262S         −            −          −           \+         \+     −      \+     −      \+     \+     \+    \+     \+     \+    \+     \+     
  **R283H**     −            −          −           \+         \+     −      \+     −      −      \+     \+    \+     \+     \+    \+     \+     
  **G312D**     −            −          \+          \+         \+     −      \+     \+     −      \+     \+    \+     \+     \+    \+     \+     
  *upps*        I63V         −          −           \+         \+     \+     −      −      \+     \+     \+    \+     \+     \+    \+     \+     \+
  K101E         −            −          −           \+         \+     −      −      −      −      \+     \+    \+     \+     \+    \+     \+     
  *vraR*        **E59D**     −          −           −          \+     \+     −      −      −      −      \+    \+     \+     \+    \+     \+     \+
  *vicK*        **R222K**    −          −           −          \+     \+     −      −      −      −      \+    \+     \+     \+    \+     \+     \+

**Notes:** Sequences in bold typeface have been reported in previous studies. Minus sign (−): sequence identical to that of N315; plus sign (+): sequence different from that of N315.

**Abbreviations:** CGMH, Chang Gung Memorial Hospital; hVISA, heterogeneous vancomycin-intermediate *Staphylococcus aureus*; MRSA, methicillin-resistant *S. aureus*; PAP/AUC, population analysis profile and area under the curve ratio; VISA, vancomycin-intermediate *S. aureus*; VSSA, vancomycin-sensitive *S. aureus*.

###### 

Amino acid sequence variations in 30 VSSA isolates

  Strain ID   Amino acid sequence variations                                   
  ----------- -------------------------------- ------- ------- ------- ------- -------
  CGMH43      −                                −       −       −       −       −
  CGMH46      −                                −       −       −       −       −
  CGMH234     −                                −       \+      \+      \+      −
  CGMH49      \+                               \+      \+      \+      \+      \+
  CGMH64      \+                               \+      \+      \+      \+      \+
  CGMH827     −                                −       −       −       \+      −
  CGMH828     −                                −       \+      \+      \+      −
  CGMH829     −                                −       \+      \+      \+      −
  CGMH830     −                                −       \+      \+      \+      −
  CGMH831     \+                               \+      \+      \+      \+      −
  CGMH832     −                                −       −       −       −       −
  CGMH833     −                                −       −       \+      \+      −
  CGMH834     −                                −       \+      \+      \+      −
  CGMH835     −                                −       \+      \+      \+      −
  CGMH836     −                                −       \+      \+      \+      −
  CGMH837     −                                −       −       −       −       −
  CGMH838     −                                −       \+      \+      \+      −
  CGMH839     −                                −       \+      \+      \+      −
  CGMH840     −                                −       \+      \+      \+      −
  CGMH841     −                                −       \+      \+      \+      −
  CGMH842     −                                −       \+      \+      −       −
  CGMH843     −                                −       \+      \+      \+      −
  CGMH844     −                                −       \+      \+      \+      −
  CGMH845     −                                −       \+      \+      \+      −
  CGMH846     −                                −       −       −       −       −
  CGMH847     −                                −       \+      \+      \+      −
  CGMH848     −                                −       \+      \+      −       −
  CGMH849     −                                −       \+      \+      \+      −
  CGMH850     −                                −       \+      \+      \+      −
  CGMH851     \+                               \+      \+      \+      \+      \+
              13.3%                            13.3%   86.7%   86.7%   76.7%   10.0%

**Notes:** Minus sign (−): sequence identical to that of N315; plus sign (+): sequence different from that of N315.

**Abbreviations:** CGMH, Chang Gung Memorial Hospital; *S. aureus, Staphylococcus aureus*; VSSA, vancomycin-sensitive *S. aureus*.

###### 

Amino acid sequence variations in 41 hVISA isolates

  Strain ID                                              Amino acid sequence variations                                        
  ------------------------------------------------------ -------------------------------- ------------ ------- ------- ------- -------------
  *P*-value[a](#tfn11-idr-11-113){ref-type="table-fn"}   4.4×10^−9^                       4.4×10^−9^   0.01    0.2     0.05    5.1×10^−10^
  CGMH33                                                 −                                −            −       −       −       −
  CGMH250                                                −                                −            −       −       −       −
  NTUH9148                                               −                                −            \+      \+      \+      −
  CGMH2                                                  \+                               \+           \+      \+      \+      \+
  CGMH6                                                  \+                               \+           \+      \+      \+      \+
  CGMH9                                                  \+                               \+           \+      \+      \+      \+
  CGMH10                                                 \+                               \+           \+      \+      \+      \+
  CGMH22                                                 \+                               \+           \+      \+      \+      \+
  CGMH23                                                 \+                               \+           \+      \+      \+      \+
  CGMH37                                                 \+                               \+           \+      \+      \+      \+
  CGMH42                                                 \+                               \+           \+      \+      \+      \+
  CGMH50                                                 \+                               \+           \+      \+      \+      \+
  CGMH55                                                 \+                               \+           \+      \+      \+      \+
  CGMH57                                                 \+                               \+           \+      \+      \+      \+
  CGMH62                                                 \+                               \+           \+      \+      \+      \+
  CGMH75                                                 \+                               \+           \+      \+      \+      \+
  CGMH82                                                 \+                               \+           \+      \+      \+      \+
  CGMH85                                                 \+                               \+           \+      \+      \+      \+
  CGMH103                                                \+                               \+           \+      \+      \+      \+
  CGMH104                                                \+                               \+           \+      \+      \+      \+
  CGMH108                                                \+                               \+           \+      \+      \+      \+
  CGMH199                                                \+                               \+           \+      \+      \+      \+
  CGMH208                                                \+                               \+           \+      \+      \+      \+
  CGMH215                                                \+                               \+           \+      \+      \+      \+
  CGMH216                                                \+                               \+           \+      \+      \+      \+
  CGMH222                                                \+                               \+           \+      \+      \+      \+
  CGMH224                                                \+                               \+           \+      \+      \+      \+
  CGMH232                                                \+                               \+           \+      \+      \+      \+
  CGMH238                                                \+                               \+           \+      \+      \+      \+
  CGMH246                                                \+                               \+           \+      \+      \+      \+
  CGMH247                                                \+                               \+           \+      \+      \+      \+
  NTUH9095                                               \+                               \+           \+      \+      \+      \+
  TSGH5046                                               \+                               \+           \+      \+      \+      \+
  TSGH5047                                               \+                               \+           \+      \+      \+      \+
  CMMC2012                                               \+                               \+           \+      \+      \+      \+
  CMMC2086                                               \+                               \+           \+      \+      \+      \+
  NTUH9140                                               \+                               \+           \+      \+      \+      \+
  CGMH236                                                −                                −            −       −       \+      −
  CGMH60                                                 \+                               \+           \+      \+      \+      \+
  CGMH72                                                 \+                               \+           \+      \+      \+      \+
  CGMH241                                                −                                −            \+      \+      \+      −
                                                         87.8%                            87.8%        92.7%   92.7%   95.1%   87.8%

**Notes:** Minus sign (−): sequence identical to that of N315; plus sign (+): sequence different from that of N315.

*P* values were generated by the Student's *t*-test by comparing the data from VISA and hVISA isolates.

**Abbreviations:** CGMH, Chang Gung Memorial Hospital; CMMC, Chi Mei Medical Center; hVISA, heterogeneous vancomycin-intermediate *Staphylococcus aureus*; NTUH, National Taiwan University Hospital; TSGH, Tri-Service General hospital; VISA, vancomycin-intermediate *S. aureus*.

###### 

Amino acid sequence variations in 16 VISA isolates

  Strain ID                                              Amino acid sequence variations                                       
  ------------------------------------------------------ -------------------------------- ------------ ------ ------ -------- ------------
  *P*-value[a](#tfn14-idr-11-113){ref-type="table-fn"}   4.2×10^−5^                       1.2×10^−6^   0.01   0.01   0.1      1.8×10^−5^
  CGMH36                                                 \+                               \+           \+     \+     \+       \+
  CGMH80                                                 \+                               \+           \+     \+     \+       \+
  CMUH4022                                               \+                               \+           \+     \+     \+       \+
  CGMH852                                                \+                               \+           \+     \+     \+       \+
  CGMH853                                                −                                −            \+     \+     \+       −
  CGMH854                                                \+                               \+           \+     \+     \+       \+
  CGMH855                                                \+                               \+           \+     \+     \+       \+
  CGMH856                                                \+                               \+           \+     \+     \+       \+
  CGMH857                                                −                                \+           \+     \+     −        −
  CMUH2021                                               \+                               \+           \+     \+     \+       \+
  TSGH188                                                \+                               \+           \+     \+     \+       \+
  TSGH204                                                \+                               \+           \+     \+     \+       \+
  TSGH205                                                \+                               \+           \+     \+     \+       \+
  TSGH218                                                \+                               \+           \+     \+     \+       \+
  TSGH243                                                \+                               \+           \+     \+     \+       \+
  TSGH257                                                \+                               \+           \+     \+     \+       \+
                                                         87.50%                           93.80%       100%   100%   93.80%   87.50%

**Notes:** Minus sign (−): sequence identical to that of N315; plus sign (+): sequence different from that of N315.

*P* values were generated by the Student's *t*-test by comparing the data from VSSA and VISA isolates.

**Abbreviations:** CGMH, Chang Gung Memorial Hospital; CMUH, China Medical University Hospital; TSGH, Tri-Service General Hospital; VISA, vancomycin-intermediate *Staphylococcus aureus*; VSSA, vancomycin-sensitive *S. aureus*.
